Diffuse large B-cell lymphoma combined with hyperlactatemia presents high mortality: case report and literature review

Abstract

Diffuse large B-cell lymphoma (DLBCL) can present with hyperlactatemia or even lactic acidosis (LA) as a rare but often underrecognized complication among hematologists. Patients diagnosed with DLBCL complicated by LA generally exhibit high mortality and a poor prognosis, even with therapeutic intervention. This report details two cases of DLBCL concurrently presenting with LA and provides a literature review. Our analysis of 19 published studies revealed a survival advantage in patients with an initial lactate levels of 5–14.9 mmol/L compared to those with levels of 15–24.9 mmol/L. Furthermore, the maximum lactate level correlated with survival, with higher values predicting shorter survival times. For type B LA, early initiation of chemotherapy-based treatment significantly improved patient survival compared to other treatment approaches (P = 0.026). Adjunctive treatments such as sodium bicarbonate, thiamine, and vitamin B may also be beneficial. Careful attention should also be paid to avoiding medications that can increase lactate levels.

Keywords

diffuse large B-cell lymphoma / hyperlactatemia / lactic acidosis

References

[1] Martelli M , Ferreri AJ , Agostinelli C , Di Rocco A , Pfreundschuh M , Pileri SA . Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 2013; 87(2): 146–171

[2] Liu QS , Harji F , Jones A , Tarnower AC. . Type B lactic acidosis: a rare oncological emergency. BMJ Case Rep 2020; 13(3):

[3] Suetrong B , Walley KR . Lactic acidosis in sepsis: it’s not all anaerobic: implications for diagnosis and management. Chest 2016; 149(1): 252–261

[4] Jin S , Chen X , Yang J , Ding J . Lactate dehydrogenase D is a general dehydrogenase for D-2-hydroxyacids and is associated with D-lactic acidosis. Nat Commun 2023; 14(1): 6638

[5] Jiang B . Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis 2017; 4(1): 25–27

[6] Vaupel P , Multhoff G . Revisiting the Warburg effect: historical dogma versus current understanding. J Physiol 2021; 599(6): 1745–1757

[7] Kobliakov VA . Tumor tissue acidosis as a factor determining the malignant phenotype and tumor resistance to chemotherapy. Cell Tissue Biol 2024; 18(5): 489–502

[8] Borde S , Matosevic S . Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities. Trends Pharmacol Sci 2023; 44(11): 832–848

[9] Chen S , Xu Y , Zhuo W , Zhang L . The emerging role of lactate in tumor microenvironment and its clinical relevance. Cancer Lett 2024; 590: 216837

[10] Crane GM , Perkins AS . Leukemic presentation of diffuse large B-cell lymphoma: an unusual pattern associated with splenic involvement. Blood 2017; 130(20): 2233

[11] Wang E , Papavassiliou P , Wei Q , Wickham MQ , Cichon L , Proia AD . An Epstein-Barr virus-positive diffuse large B-cell lymphoma presenting as multi-organ failure: a catastrophic lymphomatosis with fulminant visceral organ dissemination resulting in a precipitous death in a 59-year-old female with no identifiable etiology for immunodeficiency. Pathol Res Pract 2014; 210(1): 62–66

[12] Hafner A , Eaton DB . Acute liver failure with severe lactic acidosis secondary to infiltrative diffuse large B-cell lymphoma: an imaging-negative presentation. Cureus 2020; 12(8): e10110

[13] Gkoufa A , Georgakopoulou VE , Lakiotaki E , Cholongitas E . An unusual presentation of diffuse large B-cell lymphoma. Cureus 2022; 14(1): e20927

[14] Kumar A , Raina V . Non-Hodgkins lymphoma with lactic acidosis at presentation: a case report of a rare oncologic emergency. Indian J Med Paediatr Oncol 2014; 35(1): 83–85

[15] Keller BC , Nussensveig D , Dowell JE . Diffuse large B-cell lymphoma in a hepatitis C virus-infected patient presenting with lactic acidosis and hypoglycemia. Am J Med Sci 2010; 339(2): 202–204

[16] Sanivarapu R , Upadrista PK , Otero-Colon J , Shah K , Cadet B , Tao Q , Iqbal J . An oncological emergency: severe type B lactic acidosis from Warburg effect in diffuse large B-cell lymphoma. Cureus 2022; 14(7): e26557

[17] Weeraddana P , Odujoko O , Bal S , Mannapperuma N , Maslak D , Gupta G . An elusive diagnosis: diffuse large B-Cell lymphoma masquerading as acute liver failure with persistent lactic acidosis. Am J Case Rep 2023; 24: e941270

[18] Mohammed TJ , Gosain R , Sharma R , Torka P . Lactic acidosis: a unique presentation of diffuse large B-cell lymphoma. BMJ Case Rep 2019; 12(10): e230277

[19] Hamada T , Kaku T , Mitsu S , Morita Y , Ohno N , Yamaguchi H . Lactic acidosis and hypoglycemia in a patient with gastric diffuse large B-cell lymphoma due to the Warburg effect. Case Rep Oncol 2020; 13(2): 1047–1052

[20] He Y , Ong J , Ong S . Refractory lactic acidosis and an approach to its management—a case report. J Crit Care Med (Targu Mures) 2019; 5(2): 60–65

[21] Arif H , Zahid S , Kaura A . Persistent lactic acidosis: thinking outside the box. Cureus 2018; 10(5): e2561

[22] Masood U , Sharma A , Nijjar S , Sitaraman K . B-cell lymphoma, thiamine deficiency, and lactic acidosis. Proc Bayl Univ Med Cent 2017; 30(1): 69–70

[23] Elhomsy GC , Eranki V , Albert SG , Fesler MJ , Parker SM , Michael AG , Griffing GT . “Hyper-warburgism, ” a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin’s lymphoma. J Clin Endocrinol Metab 2012; 97(12): 4311–4316

[24] Yu D , Tang X , Xue H , Ao Y , Xie Y , Li X . Paraneoplastic syndrome in malignant lymphoma: a case report. Heliyon 2023; 9(8): e18968

[25] Hoogwerf D , van Doorn J , Maartense E . The insulin-like growth factor-system in a patient with diffuse large B-cell non-Hodgkin’s lymphoma and lactic acidosis. Ann Clin Biochem 2013; 50(2): 169–172

[26] Al Maqrashi Z , Sedarous M , Pandey A , Ross C , Wyne A . Refractory hyperlactatemia and hypoglycemia in an adult with non-Hodgkin’s lymphoma: a case report and review of the Warburg effect. Case Rep Oncol 2021; 14(2): 1159–1167

[27] Kestler MH , Gardner EM , Cohn DL . Hepatic non-Hodgkin’s lymphoma with lactic acidosis in HIV-infected patients: report of 2 cases. J Int Assoc Physicians AIDS Care (Chic) 2010; 9(5): 301–305

[28] Tanios G , Aranguren IM , Goldstein JS , Patel CB . Diffuse large B-cell lymphoma: a metabolic disorder. Am J Case Rep 2013; 14: 518–525

[29] Chaba A , Fodil S , Lemiale V , Mariotte E , Valade S , Azoulay E , Zafrani L . Clinical Warburg effect in lymphoma patients admitted to intensive care unit. Ann Intensive Care 2023; 13(1): 97

[30] Sia P , Plumb TJ , Fillaus JA . Type B lactic acidosis associated with multiple myeloma. Am J Kidney Dis 2013; 62(3): 633–637

[31] Alfaifi A , Bahashwan S , Alsaadi M , Malhan H , Aqeel A , Al-Kahiry W , Almehdar H , Qadri I . Metabolic biomarkers in B-cell lymphomas for early diagnosis and prediction, as well as their influence on prognosis and treatment. Diagnostics (Basel) 2022; 12(2): 394

[32] Cao Y , Chen P , Cai M , Shi Q , Xu P , Wang L , He Y , Wang H , Zhao W . Prognostic impact of B-vitamins involved in one-carbon metabolism in patients with diffuse large B-cell lymphoma. Hematol Oncol 2020; 38(4): 456–466

[33] Hamaguchi R , Isowa M , Narui R , Morikawa H , Wada H . Clinical review of alkalization therapy in cancer treatment. Front Oncol 2022; 12: 1003588

[34] Halperin ML , Cheema-Dhadli S , Halperin FA , Kamel KS . Rationale for the use of sodium bicarbonate in a patient with lactic acidosis due to a poor cardiac output. Nephron J 1994; 66(3): 258–261

[35] Piha-Paul S , Simon G , Belani CP , Chao H , Gaspar K , Lee B , Dowlati A . A phase 1, open-label, dose-escalation study of L-DOS47 in combination with pemetrexed plus carboplatin in patients with stage IV recurrent or metastatic nonsquamous NSCLC. JTO Clin Res Rep 2022; 3(11): 100408

[36] Wesson DE , Mathur V , Tangri N , Stasiv Y , Parsell D , Li E , Klaerner G , Bushinsky DA . Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet 2019; 394(10196): 396–406

[37] Kraut JA , Madias NE . Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 2012; 8(10): 589–601

[38] Wu D , Qi J , Dai H , Doods H , Abraham WM . Resuscitation with Na⁺/H⁺ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol 2010; 37(3): 337–342

[39] De Backer D , Creteur J , Dubois MJ , Sakr Y , Koch M , Verdant C , Vincent JL . The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34(2): 403–408

[40] Zanza C , Facelli V , Romenskaya T , Bottinelli M , Caputo G , Piccioni A , Franceschi F , Saviano A , Ojetti V , Savioli G , Longhitano Y . Lactic acidosis related to pharmacotherapy and human diseases. Pharmaceuticals (Basel) 2022; 15(12): 1496

Rights & permissions

Higher Education Press